128 related articles for article (PubMed ID: 10680962)
1. Green fluorescence protein as a transcriptional reporter for the long terminal repeats of the human immunodeficiency virus type 1.
Kar-Roy A; Dong W; Michael N; Li Y
J Virol Methods; 2000 Feb; 84(2):127-38. PubMed ID: 10680962
[TBL] [Abstract][Full Text] [Related]
2. A quantitative GFP-based bioassay for the detection of HIV-1 Tat transactivation inhibitors.
Daelemans D; De Clercq E; Vandamme AM
J Virol Methods; 2001 Aug; 96(2):183-8. PubMed ID: 11445148
[TBL] [Abstract][Full Text] [Related]
3. An adenovirus-based fluorescent reporter vector to identify and isolate HIV-infected cells.
Richman L; Meylan PR; Munoz M; Pinaud S; Mirkovitch J
J Virol Methods; 2002 Jan; 99(1-2):9-21. PubMed ID: 11684299
[TBL] [Abstract][Full Text] [Related]
4. Effect of insulin-like growth factor I on HIV type 1 long terminal repeat-driven chloramphenicol acetyltransferase expression.
Germinario RJ; Colby-Germinario SP; Acel A; Chandok R; Davison K; Mak J; Kleiman L; Faust E; Wainberg MA
AIDS Res Hum Retroviruses; 1999 Jun; 15(9):829-36. PubMed ID: 10381171
[TBL] [Abstract][Full Text] [Related]
5. High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B.
Negrini M; Rimessi P; Sabbioni S; Caputo A; Balboni PG; Gualandri R; Manservigi R; Grossi MP; Barbanti-Brodano G
Biotechniques; 1991 Mar; 10(3):344-53. PubMed ID: 1829615
[TBL] [Abstract][Full Text] [Related]
6. A high-level expression vector for human cells.
Subramanian T; Chinnadurai G
Gene; 1992 Oct; 120(2):287-9. PubMed ID: 1398142
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 Tat protein can transactivate a heterologous TATAA element independent of viral promoter sequences and the trans-activation response element.
Roebuck KA; Rabbi MF; Kagnoff MF
AIDS; 1997 Feb; 11(2):139-46. PubMed ID: 9030359
[TBL] [Abstract][Full Text] [Related]
8. A sensitive promoter assay based on the transcriptional activator Tat of the HIV-1 virus.
Koken SE; van Wamel J; Berkhout B
Gene; 1994 Jul; 144(2):243-7. PubMed ID: 8039709
[TBL] [Abstract][Full Text] [Related]
9. Detection of HIV-1 infection with a green fluorescent protein reporter system.
Dorsky DI; Wells M; Harrington RD
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Dec; 13(4):308-13. PubMed ID: 8948367
[TBL] [Abstract][Full Text] [Related]
10. Cytokine augmentation of HIV-1 LTR-driven gene expression in neural cells.
Swingler S; Easton A; Morris A
AIDS Res Hum Retroviruses; 1992 Apr; 8(4):487-93. PubMed ID: 1599755
[TBL] [Abstract][Full Text] [Related]
11. Towards developing HIV-2 lentivirus-based retroviral vectors for gene therapy: dual gene expression in the context of HIV-2 LTR and Tat.
Sadaie MR; Zamani M; Whang S; Sistron N; Arya SK
J Med Virol; 1998 Feb; 54(2):118-28. PubMed ID: 9496370
[TBL] [Abstract][Full Text] [Related]
12. Translational effects of peptide antagonists of Tat protein of human immunodeficiency virus type 1.
Choudhury I; Wang J; Stein S; Rabson A; Leibowitz MJ
J Gen Virol; 1999 Mar; 80 ( Pt 3)():777-782. PubMed ID: 10092019
[TBL] [Abstract][Full Text] [Related]
13. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
[TBL] [Abstract][Full Text] [Related]
14. Mutation of the major 5' splice site renders a CMV-driven HIV-1 proviral clone Tat-dependent: connections between transcription and splicing.
Bohne J; Kräusslich HG
FEBS Lett; 2004 Apr; 563(1-3):113-8. PubMed ID: 15063733
[TBL] [Abstract][Full Text] [Related]
15. Lack of responsiveness of a nuclear factor-kappaB-regulated promoter to transactivation by human immunodeficiency virus 1 Tat in HeLa cells.
Kelly GD; Morris CB; Offermann MK
Virology; 1999 Oct; 263(1):128-38. PubMed ID: 10544088
[TBL] [Abstract][Full Text] [Related]
16. Tat transactivation of the human immunodeficiency virus type 1 promoter is influenced by basal promoter activity and the simian virus 40 origin of DNA replication.
Kessler M; Mathews MB
Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10018-22. PubMed ID: 1658792
[TBL] [Abstract][Full Text] [Related]
17. Cellular factors regulate transactivation of human immunodeficiency virus type 1.
Barry PA; Pratt-Lowe E; Unger RE; Luciw PA
J Virol; 1991 Mar; 65(3):1392-9. PubMed ID: 1995949
[TBL] [Abstract][Full Text] [Related]
18. Ribozyme targeting of HIV-1 LTR.
Ventura M; Wang P; Franck N; Saragosti S
Biochem Biophys Res Commun; 1994 Sep; 203(2):889-98. PubMed ID: 8093072
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.
Mayhood T; Kaushik N; Pandey PK; Kashanchi F; Deng L; Pandey VN
Biochemistry; 2000 Sep; 39(38):11532-9. PubMed ID: 10995220
[TBL] [Abstract][Full Text] [Related]
20. Trans-activation of the long terminal repeat of human immunodeficiency virus type 1 by the parvovirus B19 NS1 gene product.
Sol N; Morinet F; Alizon M; Hazan U
J Gen Virol; 1993 Sep; 74 ( Pt 9)():2011-4. PubMed ID: 8376975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
